Shaw Christi

Director at AVTR; SVP and Pres., Lilly Bio-Meds at LLY

Sold, on record
$2M
Dollars the filings state
Form 4 sales
3
Latest Dec 11, 2020
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • AVTRAvantor, Inc.Director
  • LLYELI LILLY & CoSVP and Pres., Lilly Bio-Meds

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale LLYUnusual
    May 29 2018

    Sold 8,426 shares at $82.10 ($692k)

    Shaw Christi, SVP and Pres., Lilly Bio-Meds

    Sold 100% of holdings ($692k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LLYUnusual
    May 3 +339 days

    Sold 7,577 shares at $117.14 ($888k)

    Shaw Christi, SVP and Pres., Lilly Bio-Meds

    Sold 100% of holdings ($888k position)0 shares leftFiling

  3. 3 Form 4 sale AVTRUnusual
    Dec 11 +588 days

    Sold 14,286 shares at $26.68 ($381k)

    Shaw Christi, Director

    Sold 55.8% of holdings ($683k position)11,319 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Shaw Christi
Source
Dec 11, 2020AVTRDirectorForm 4 sale14,286$381k55.8%UnusualSEC
May 3, 2019LLYSVP and Pres., Lilly Bio-MedsForm 4 sale7,577$888k100.0%UnusualSEC
May 29, 2018LLYSVP and Pres., Lilly Bio-MedsForm 4 sale8,426$692k100.0%UnusualSEC